Common Stock SEC Reporting - Delinquent
Pink No Information
Contact Info
  • 2040 Whitfield Avenue
  • Suite 300
  • Sarasota, FL 34243

Business Description

Update Company Profile
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2016 10-Q
CIK 0000776008
Fiscal Year End 12/31
OTC Marketplace Pink No Information
Profile Data
SIC - Industry Classification 2833 - Medicinal and botanicals
Incorporated In: DE, USA
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Michael J. Mullan CEO
William McMahon Interim CFO
Theodore Jenkins VP, Corp. Dev., IR, Corporate Secretary
Company Directors
Michael J. Mullan Chairman
Lee Canaan
Robert Scannell
Service Providers
Accounting/Auditing Firm
Cherry, Bekaert & Holland, L.L.P.
P.O. Box 25549
Richmond, VA, 23260-5500
United States
Securities Counsel
Foley & Lardner LLP
100 North Tampa Street
Suite 2700
Tampa, FL, 33601-3391
United States
Investor Relations Firm
PCG Advisory Group
535 Fifth Avenue
24th Floor
New York, NY, 10017
United States
Company History
  • Note = Rock Creek Pharmaceuticals, Inc., together with its two wholly owned subsidiaries - RCP Development, Inc. and Star Tobacco, Inc. filed voluntary petitions under Chapter 7 of the United States Bankruptcy Code in the District of Delaware on September 27, 2016.
  • Formerly=Star Scientific, Inc. until 6-2014
  • Formerly=Eye Technology, Inc. until 12-98
RCPIQ Security Details
Share Structure
Market Value1 $170,445 a/o Oct 20, 2017
Authorized Shares 314,800,000 a/o Mar 24, 2016
Outstanding Shares 170,444,758 a/o Aug 03, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value Not Available
Shareholders of Record 580 a/o Mar 22, 2016
Short Selling Data
Short Interest 11,037 (17,993.439%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security